?

Jellison William R

Director
Anika Therapeutics, Inc.
US, Bedford [HQ]
CIK 1189883

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
6,239
Price per Share :
$16.19
Equivalence :
$101,009.41

Transaction History

  • A
    Form 4
    6,239 Shares After Transaction
    Value : $n/a
    $0.0
    07/09/24
  • Footnotes:
    #1 These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2025 annual meeting of the Company's stockholders or July 9, 2025.
  • A
    Form 4
    3,168 Shares After Transaction
    Value : $n/a
    $0.0
    06/03/24